Pharmiwebcom

05/03/2026

Robert F Kennedy Jr: 1 year of failure

In his first speech as Secretary of the US Department of Health and Human Services (HHS), Robert F Kennedy Jr laid out a plan to restore trust. The COVID-19 pandemic saw public faith in Federal health and science plummet—between April, 2020, and September, 2023, the percentage of polling responden...

29/01/2026

Stanford Medicine scientists have uncovered a promising way to reverse cartilage loss in aging knees and prevent arthritis after injury by targeting a protein linked to aging. In research recently published and shared by Stanford, blocking a protein known to rise with age helped restore healthy knee cartilage in older mice and reduced arthritis development after injuries similar to common ligament tears. Treated mice regained thicker, functional cartilage and showed improved joint movement co...

https://www.pharmiweb.com/pwtoday-story/stanford-researchers-reveal-breakthrough-method-to-regenerate-knee-cartilage?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost

28/01/2026

Evestia Clinical has announced the acquisition of ICRC-Weyer GmbH, a well-established contract research organisation and scientific consultancy based in Berlin. This move strengthens Evestia Clinical’s full-service clinical research capabilities by bringing specialist expertise in biostatistics, data management and medical writing into its global offering. The deal also reinforces the company’s presence in Germany and across Europe, providing biotech innovators with more integrated support th...

https://www.pharmiweb.com/pwtoday-story/evestia-clinical-expands-european-reach-with-icrc-weyer-acquisition?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost

27/01/2026

South Korean contract manufacturer ST Pharm has sealed a supply contract worth $56 million to provide active pharmaceutical ingredients (APIs) for an oligonucleotide therapeutic developed by an unnamed US biotech company. The deal covers manufacture of oligonucleotide raw materials for a prospective treatment targeting severe hypertriglyceridemia and represents roughly 30 percent of ST Pharm’s 2024 revenue, underscoring its expanding footprint in the global API market. The supply agreement ru...

https://www.pharmiweb.com/pwtoday-story/st-pharm-wins-56-million-oligonucleotide-api-supply-deal-with-us-biotech?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost

22/01/2026

Otsuka Pharmaceutical, in partnership with Ionis Pharmaceuticals, has secured European Commission approval for Dawnzera (donidalorsen) in the European Union as a preventative treatment for hereditary angioedema (HAE) in adults and adolescents aged 12 and older. This decision comes after a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use, which reviewed data demonstrating that Dawnzera can significantly reduce the frequency of debilitating HA...

https://www.pharmiweb.com/pwtoday-story/otsuka-s-dawnzera-wins-european-commission-approval-for-hereditary-angioedema-prevention?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost

20/01/2026

DeepHow has introduced PharmaCloud, a cloud-based platform designed specifically for pharmaceutical and medical device manufacturers to improve training, ex*****on, and verification on the factory floor. PharmaCloud provides a GMP-compliant environment that helps teams standardize procedures across sites so operators follow approved methods with greater consistency and fewer errors than traditional training.

The platform unifies training content, guided step-by-step ex*****on, and AI-powered...

https://www.pharmiweb.com/pwtoday-story/deephow-launches-pharmacloud-to-standardize-pharma-manufacturing-training?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost

16/01/2026

Sanofi has secured European Union approval for Teizeild (teplizumab), a new disease-modifying therapy for people aged eight years and older with stage 2 type 1 diabetes. This decision by the European Commission follows a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use and makes Teizeild the first treatment in the EU shown to delay the onset of stage 3 clinical type 1 diabetes.

The approval is based on positive results from the TN-10 phase I...

https://www.pharmiweb.com/pwtoday-story/sanofi-s-teizeild-gains-first-eu-approval-to-delay-type-1-diabetes-progression?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost

16/01/2026

QPS Holdings, LLC, an award-winning contract research organisation focused on clinical trials and bioanalysis, has implemented the Oracle Argus Safety Database to elevate its pharmacovigilance capabilities. This industry-leading safety case management system will support QPS in capturing, managing and reporting adverse event data across clinical trials with greater efficiency and compliance. By adopting Argus, QPS aims to improve patient safety oversight, strengthen regulatory compliance and...

https://www.pharmiweb.com/pwtoday-story/qps-selects-oracle-argus-safety-to-strengthen-pharmacovigilance-in-clinical-trials?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost

17/12/2025

GlaxoSmithKline announced that the US Food and Drug Administration has approved its twice-annual asthma therapy Exdensur, offering a new option for patients aged 12 and older with severe eosinophilic asthma inadequately controlled by standard treatment.

Exdensur, known by its active ingredient depemokimab, is designed as an add-on maintenance treatment that can be administered just twice a year, potentially improving convenience and adherence for patients living with persistent symptoms. The...

https://www.pharmiweb.com/pwtoday-story/gsk-s-exdensur-gains-us-fda-approval-for-severe-asthma-treatment?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost

16/12/2025

Search 1,509 Pharma & Life Science Jobs - https://bit.ly/490RZnb

- Clinical Research (607) - https://bit.ly/4qcna5R
- Sales / Commercial (189) - https://bit.ly/3MJgr4L
- Data Management / Statistics (107) - https://bit.ly/4qd1qXA
- Finance / Administration (85) - https://bit.ly/4sf6nku
- Regulatory Affairs (66) - https://bit.ly/48FoVCD
- Operations (65) - https://bit.ly/4qcnamn
- Manufacturing (59) - https://bit.ly/45bhSiG
- R & D (57) - https://bit.ly/4aktwLU
- Medical Affairs (53) - https://bit.ly/49eKEkX
- Quality (45) - https://bit.ly/4qbbIas
- Information Technology (41) - https://bit.ly/4s0TlGU
- Project Management (37) - https://bit.ly/3XTtUJP
- Healthcare (36) - https://bit.ly/3MFb4nl
- Medical Communications (30) - https://bit.ly/4qf5eHH
- HEOR (29) - https://bit.ly/4rYcOIv
- Marketing (29) - https://bit.ly/4rVgaMp
- HR / Recruitment / Training (15) - https://bit.ly/3MJgsWn

Register & Upload Your CV Now! https://bit.ly/4pH99gL
Follow us on LinkedIn: PharmiWeb.jobs: Global Life Science Jobs

Search Thousands of Pharma & Life Science Jobs in 2023

11/12/2025

https://www.pharmiweb.jobs